The S&P/ASX 200 index returned to form last week thanks to the easing of trade tensions between the US and China. The benchmark index recorded a 34-point or 0.5% gain to finish the week at 6647.3 points.
Unfortunately, not all shares followed the index higher. Here’s why these shares were the worst performers on the S&P/ASX 200 index last week:
The CYBG PLC (ASX: CYB) share price was the worst performer on the ASX 200 index by some distance last week with a decline of 21.8%. Investors were quick to hit the sell button after the UK-based bank was forced to increase its provisions for legacy PPI costs by between £300 million and £450 million. Management advised that this was primarily due to an unprecedented volume of PPI Information Requests received during August in advance of the August 29 deadline. This was significantly more than the market had expected and appeared disproportionately large in comparison to its peers.
The Pro Medicus Limited (ASX: PME) share price was the next worst performer on the benchmark index last week with a 9.3% decline. All of this decline came on Friday after the healthcare technology company revealed that two of its founders had sold 1 million of the company’s shares each. Executive director Anthony Hall and CEO Sam Hupert sold the shares through an underwritten block trade this morning for a total of $36.1 million each. However, the market was informed of these planned sales all the way back in February 2018, so the selling appears to have been an overreaction.
The Sigma Healthcare Ltd (ASX: SIG) share price was out of form last week and dropped 7.8% lower last week. The catalyst for this was the pharmacy chain operator and distributor’s half year results. Sigma posted a disappointing 19.8% decline in EBITDA compared to the prior corresponding period and provided weaker than expected guidance for the near term. In addition to this, on Friday S&P Dow Jones indices announced that Sigma would be removed from the S&P/ASX 200 index at the next quarterly rebalance.
The Spark Infrastructure Group (ASX: SKI) share price wasn’t far behind with a disappointing 6.5% decline over the period. The regulated utility infrastructure company’s shares dropped lower last week after trading ex-dividend for its 7.5 cents per share interim dividend. This dividend will now be paid to eligible shareholders on September 13.
Need a lift after these declines? Then check out these top growth shares which have been labeled as must buys.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.